Drug Therapy

Citations 151-160 of 471 total displayed.

Past content (since Nov 1998):

Correspondence
Eczematoid Graft-vs-Host Disease

Robert H. Cook-Norris; Roger H. Weenig
Arch Dermatol 2008; 144: 1066. [Extract] [Full text] [PDF]  

Correspondence
The Role of Narrowband UV-B Plus Alefacept Combination Therapy in the Treatment of Psoriasis

Heidi Jacobe; Laura Winterfield; Flora Kim; Beverley Huet-Adams; Rachael Cayce
Arch Dermatol 2008; 144: 1067-1068. [Extract] [Full text] [PDF]  

Correspondence
The Role of Narrowband UV-B Plus Alefacept Combination Therapy in the Treatment of Psoriasis—Reply

Franz J. Legat; Franz Quehenberger; Peter Wolf
Arch Dermatol 2008; 144: 1068-1069. [Extract] [Full text] [PDF]  

Correspondence
The Use of Patch Tests in Determining Hypersensitivity to Etanercept and Infliximab

Lidian L. A. Lecluse; Gamze Piskin; Jan D. Bos
Arch Dermatol 2008; 144: 1070-a-1071-a. [Extract] [Full text] [PDF]  

Correspondence
The Use of Patch Tests in Determining Hypersensitivity to Etanercept and Infliximab—Reply

Julien Seneschal; Brigitte Milpied; Alain Taïeb
Arch Dermatol 2008; 144: 1071-1072. [Extract] [Full text] [PDF]  

Correspondence
Therapeutic Effect of Argatroban on Rheumatoid Vasculitis With Antiphosphatidylserine-Prothrombin Complex Antibody

Tamihiro Kawakami; Masahide Yamazaki; Kanade Kawasaki; Masako Mizoguchi; Yoshinao Soma
Arch Dermatol 2008; 144: 1075-1076. [Extract] [Full text] [PDF]  

Correspondence
Palmar-Plantar Erythrodysesthesia Caused by Mercaptopurine and Mesalamine

Karolyn A. Wanat; Grace D. Bandow; Paul A. Klekotka
Arch Dermatol 2008; 144: 1079-1081. [Extract] [Full text] [PDF]  

Correspondence
Palmar-Plantar Erythrodysesthesia Secondary to Sunitinib Treatment Resulting in Necrotic Foot Syndrome Aggravated by Background Diabetic Vascular Disease

Emmanuella Guenova; Hans Oliver Weber; Bogmil Voykov; Gisela Metzler; Vanyo Mitev; Mark Berneburg; Wolfram Hoetzenecker; Martin Röcken
Arch Dermatol 2008; 144: 1081-1082. [Extract] [Full text] [PDF]  

The Cutting Edge
Dapsone Treatment for Eosinophilic Fasciitis

Lynsey C. Smith; Neil H. Cox
Arch Dermatol 2008; 144: 845-847. [Extract] [Full text] [PDF]  

Studies
Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase Inhibitor

Julien Autier; Bernard Escudier; Janine Wechsler; Alain Spatz; Caroline Robert
Arch Dermatol 2008; 144: 886-892. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48